Skip to main content

Table 1 Demographic and clinical data of MDD patients with SSRIs and healthy controls

From: Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs

Variables

MDD Patients with SSRIs

Healthy Controls

F or χ2

p

N = 30, Mean (SD)

N = 101, Mean (SD)

Gender (male/female)

11/19

52/49

1.48

0.22

Age (years)

39.73 (15.66)

37.38 (12.13)

0.76

0.39

Education (years)

10.07 (3.39)

13.00 (2.90)

21.87

< 0.001

Marriage (unmarried/married/divorced)

8/21/1

31/68/2

0.11

0.95

BMI (kg/m2)

22.51(3.07)

22.94 (3.03)

0.43

0.51

Smoking (smoker/nonsmoker)

27/3

76/25

1.96

0.16

Drinking (drinker/nondrinker)

26/4

92/9

0.13

0.72

Age of Onset (years)

36.59 (14.80)

-

-

-

Hospitalization Number

1.52 (0.87)

-

-

-

Duration of Illness (years)

3.90 (4.27)

-

-

-

HAMD Score

22.03 (6.49)

-

-

-

  1. Abbreviations: MDD Major depressive disorder, SD Standard deviation, SSRIs Selective serotonin reuptake inhibitors, BMI Body mass index, HAMD Hamilton Depression Scale